3T Biosciences develops transformative T-cell receptor (TCR) therapeutics aimed at treating solid tumors and immune-mediated diseases in diverse patient populations. The company addresses the limitations of current immunotherapies by enhancing the specificity and efficacy of T-cell responses against cancer cells.

Aavia is a hormone health app that utilizes data tracking and analysis to provide personalized insights on mood, energy levels, and menstrual symptoms for individuals with ovaries. By enabling users to log their health data, Aavia helps them understand their hormonal patterns and receive tailored recommendations to improve their overall well-being.

The startup develops a selective ALDH2 inhibitor that regulates dopamine levels to mitigate cravings associated with substance use disorders. This technology enables patients to overcome addiction to drugs, alcohol, and smoking without altering their baseline dopamine levels.

The startup offers a clinical data registry platform that utilizes encryption algorithms to securely share and manage sensitive healthcare data while maintaining compliance with regulations. This technology enables hospitals to control and trace patient data effectively, facilitating accelerated research without compromising data ownership or security.

Autonomize AI provides a trusted AI platform purpose-built for healthcare to augment complex knowledge workflows. The platform utilizes Compound AI Agents and Multi-agent Orchestration to automate tasks like prior authorization, medical record review, and clinical research matching. This results in reduced administrative burden, improved decision-making efficiency, and better patient outcomes for health plans and life sciences organizations.

basys.ai provides enterprise-grade Generative AI solutions specifically for the healthcare industry. The platform automates complex workflows such as prior authorization, utilization management, and payment integrity processes. This technology delivers high clinical accuracy and significantly accelerates decision-making times for payers and providers.

Carta Healthcare combines artificial intelligence with expert clinical data abstractors to enhance the speed and quality of clinical data abstraction for healthcare registries. This approach addresses the inefficiencies of traditional data abstraction methods, which are often time-consuming, labor-intensive, and costly, by delivering high-quality data more efficiently.

Decent provides health plans built around the Direct Primary Care (DPC) model, which eliminates out-of-pocket costs by connecting members with dedicated primary care providers for personalized care. This approach reduces healthcare expenses by up to 40% compared to traditional plans while enhancing member satisfaction, as evidenced by a Net Promoter Score of 79.

Endless Health provides wellness professionals with an integrated platform featuring precision testing, practice management software, and strategic launch support. The company streamlines operations by offering tools for clinical tracking, client management, and compliant service delivery. This infrastructure enables longevity practices to personalize care strategies and scale their businesses efficiently.

Evidation develops a health data analytics platform that collects and analyzes high-frequency behavior data from sensors, devices, and other sources to generate actionable health insights. The platform enables individuals and organizations to understand and influence daily behaviors that impact health outcomes, while allowing users to control their data and earn rewards for healthy activities.

Freenome provides a blood‑based early cancer detection platform that uses multiomics profiling—integrating genomics, epigenomics, proteomics, and metabolomics—with AI‑driven analysis to identify cancer at its most treatable stages. The minimally invasive test is designed for routine screening across multiple cancer types and is validated through ongoing clinical programs for use by healthcare providers.

Gilead Sciences discovers, develops, and delivers innovative therapeutics for serious viral, oncologic, and inflammatory diseases, maintaining a portfolio of over 25 approved medicines and a pipeline of 47 clinical‑stage programs. The company expands global access through licensing, partnerships, and philanthropy, reaching patients in more than 120 countries while integrating ESG initiatives to support sustainable health outcomes.

Keepsafe provides mobile apps for iOS and Android that encrypt and lock personal photos, videos, and documents using AES‑256 encryption, with access controlled by PIN, biometric or face‑down gestures. The apps include automatic encrypted cloud backup, decoy icons, permission‑based sharing, and premium plans that add expanded storage and advanced security controls.

Lark offers a digital Diabetes Prevention Program that utilizes AI coaching, smart devices, and tele-monitoring to help users achieve weight loss and manage their health remotely. The program provides 24/7 access to personalized coaching and resources, aiming to reduce the risk of diabetes for participants, often at no cost with eligible insurance.

Mightier is a gaming platform that combines a Bluetooth-connected heart sensor with over 25 interactive games to help children aged 6-14 develop emotional regulation skills. The program is clinically validated to assist kids with anxiety, ADHD, and autism, providing measurable improvements in emotional awareness and coping strategies within 90 days.

Mozio is a global ground transportation marketplace that aggregates airport shuttles, taxis, and private buses into a single booking platform. It offers travelers a unified interface for point-to-point and hourly rides, with features like free cancellations and flight delay monitoring.

The company delivers AI-driven security and infrastructure services that streamline workflows and increase productivity across multiple industries. Its healthcare solutions use AI to improve patient interactions for physicians and radiologists, while its speech‑recognition tools enhance general workplace efficiency.

Om provides access to massive, internally generated datasets detailing proteome-wide small molecule binding data. Researchers can programmatically query billions of protein and small molecule interaction data points to identify therapeutic opportunities instantly. The platform leverages synthetic biology and pico-scale engineering to accelerate the transition from hypothesis to launching a discovery program.

Outcomes4Me is an AI‑driven mobile platform that consolidates NCCN‑based treatment guidelines, genomic data, and clinical‑trial matching to deliver personalized cancer care plans. It enables patients to track symptoms and medications in real time, receive side‑effect alerts, and connect with disease‑specific peer communities, while securely sharing data with clinicians for coordinated care.

Pluto unifies siloed medical, insurance, and social determinants of health data from most US health systems to create a comprehensive patient picture. The platform applies AI-driven clinical intelligence to identify care gaps and opportunities for improved health access and outcomes. It then facilitates the delivery of necessary care resources, such as screenings and at-home labs, closing the loop on coordination for providers, payors, and life sciences partners.

Provides a vacation rental management platform that automates scheduling, standardizes cleaning procedures, and enables real-time property inspections through photo verification and live feedback. This system ensures consistent quality between guest stays, reduces operational errors, and connects hosts with a vetted network of service providers to maintain high standards at scale.

OneStudyTeam offers a cloud‑based collaboration platform that centralizes clinical trial workflows for sponsors, CROs, sites, patients, and regulators. The solution provides real‑time enrollment dashboards, integrated pre‑screening linked to EHRs, and bi‑directional APIs with CTMS and eTMF systems, while maintaining GCP, HIPAA, and 21 CFR Part 11 compliance. Predictive analytics and modular plug‑ins help accelerate recruitment and reduce manual data handling.

The startup develops wearable medical technology that utilizes genomic data and artificial intelligence for the early detection of pediatric diseases, specifically focusing on autism. By integrating clinical informatics and electrical engineering, the technology enables healthcare professionals to diagnose conditions sooner, facilitating timely interventions and improved patient outcomes.

SubjectWell is a patient recruitment platform that utilizes machine learning to match healthcare-motivated patients with clinical studies across various therapeutic areas, ensuring a diverse and pre-qualified patient pool. By streamlining the connection between sponsors, CROs, and patients, SubjectWell reduces the time to start screening patients from weeks to days, enhancing the efficiency of clinical trials.